🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

awbs://authors.elsevier.com/a/1c%7EaQ6gYCvEjpq

Hope this one goes through... AddThis | Home authors.elsevier.com/a/1c~aQ6gYCvEj…

Our pilot report on the diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi: doi.org/10.1111/cup.14… Carlos Torres-Cabala, MD Dr. Victor Prieto #dermpath #pathology

Hot off the press! We are pleased to share our experience of using #DigiPath to improve our non-#dermpath trainees’ diagnostic skills in pigmented cutaneous lesions during the #COVID19 pandemic. Free access for 50 days! Pavandeep Gill Carlos Torres-Cabala, MD sciencedirect.com/science/articl…

#dermpath POP QUIZ!! Spotted in Houston during an exhilarating sign out! Is this a BCC or a shark? 🦈 😄Mehran Taherian, MD Carlos Torres-Cabala, MD Dr. Victor Prieto @PNagarajanMDACC Kaitlin Vanderbeck, MD, FRCPC, FCAP, FASDP Dr Phyu P Aung

Our recent article on #DigitalPath for pathology education (esp. focusing on #DermPath diagnostic skills) has been featured in DocWire News! 😆🔬 Pavandeep Gill Dr Phyu P Aung @PNagarajanMDACC Dr. Victor Prieto Carlos Torres-Cabala, MD docwirenews.com/abstracts/the-…

Here, @AGiubeMD Carlos Torres-Cabala, MD et al describe a #melanoma tumour with a dual phenotype that corresponds with different molecular profiles within the tumour. Understanding this #heterogeinity can help define biomarkers & more effective targeted therapies: onlinelibrary.wiley.com/doi/10.1111/pc…

In a virtual panel discussion, our experts will provide practical and useful examples of how to best manage and treat patients with skin cancers. Registration is open for the Feb. 12 event: mdanderson.cloud-cme.com/course/courseo… Carlos Torres-Cabala, MD Dr Phyu P Aung SunDog #Melanoma #EndCancer

Congratulations to MD Anderson Cancer Center' @JFueyoMargareto and @VGPrieto14 for their election as 2021 @AAAS Fellows. This profound honor recognizes their outstanding contributions to cancer research and their relentless commitment to advancing our mission to #EndCancer.

Yay… congratulations Dr Prieto. Very well deserved. So proud of my boss🍾🎊🎉👏

New in #HumPathol: Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. sciencedirect.com/science/articl… #pathology #PathTwitter #dermpath #hemepath

On the 30th of October, I will be coordinating with Dr. Carlos Torres-Cabala, MD, the #dermatopathology session. Register and be part of the #IAP2024 Cancún, México. 🔬🇲🇽 cslide.ctimeetingtech.com/iap24/attendee…

🔊Happy to share the Special Issue "Histopathology and Pathogenesis of Skin Cancer" edited by Prof. Dr. Carlos Torres-Cabala, MD and Dr. Alessio Giubellino which is open for submissions❗ 🗓Deadline for manuscript submissions: 20 December 2025. 🔗Find out more here mdpi.com/journal/cancer…

Looks like someone I see every day! 😆🔬🎉🎉🎉 Huge congrats to Carlos Torres-Cabala, MD and all the #MDACCPath #dermpath grads who learned from him! Pavandeep Gill Volha (Olga) Lenskaya Aimi T. Rothrock, MD Kaitlin Vanderbeck, MD, FRCPC, FCAP, FASDP Ziba Rahbar, MD, MPH Yi Ariel Liu, MD Jonathan He Shaymaa Hegazy Shane Smith, MD

#IAP2024 Dermatopathology symposium Carlos Torres-Cabala, MD We continue with the best experts. Cutaneous Lymphomas

Many thanks to Marcela ⁦Marcelasaeblima.⁩ and Carlos ⁦Carlos Torres-Cabala, MD⁩ for organizing a fantastic skin session! 😀#IAP2024

DíaDeMuertos☠️🇲🇽🖤 #Dermatopatología🔬 #IAP2024 Cancún. Puro top.

Full room. #IAP2024 #Dermatopathology🔬💕 RULES!

#Dermpath session at #IAP2024 MSLDERMATOPATO Arnaud de la Fouchardiere MD, PhD Thomas Brenn